- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
|International Nonproprietary Names|
|ABT-555 | AE12-1Y-QL|
|Elezanumab (ABT-555) is a fully human monoclonal antibody targeting repulsive guidance molecule-a (RGMA), in development as a potential therapy for multiple sclerosis (MS).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide anaylsis reveals identical matches with peptides claimed in patent WO2013112922 .
|GtoPdb PubChem SID||318164809|
|Search PubMed clinical trials||elezanumab|
|Search PubMed titles||elezanumab|
|Search PubMed titles/abstracts||elezanumab|